Kiromic BioPharma, Inc. (KRBP) Financials

KRBP Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 14.2 million 18.7 million
2023-06-30 13.6 million 19.9 million
2023-03-31 12.0 million 17.7 million
2022-12-31 12.0 million 17.7 million

KRBP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -5.3 million 26400
2023-06-30 -6.5 million 35400
2023-03-31 -4.2 million 609600
2022-12-31 -4.2 million 609600

KRBP Net Income

No data available :(

KRBP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 4.4 million - 1.7 million
2023-06-30 2.7 million - 1.8 million
2023-03-31 645200 - 2.0 million
2022-12-31 - - 2.1 million

KRBP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 1.2 million
2023-06-30 1.1 million
2023-03-31 544529
2022-12-31 683490

KRBP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 97500 2.7 million 2.9 million -
2023-06-30 - 2.0 million 2.3 million -
2023-03-31 57200 3.3 million 3.6 million -
2022-12-31 57200 3.3 million 3.6 million -

KRBP Cost of Revenue

No data available :(

KRBP

Price: $2.44

52 week price:
0.16
8.97

Earnings Per Share: -12.59 USD

P/E Ratio: -0.07

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 1.8 million

Market Capitalization: 3.8 million

Links: